Request Trial
23 November 2024NewsAmericasChristina MacDougall, Partner, Morgan Lewis | Susan Evans, Senior Director, Intellectual Property, IGM Biosciences | Lawrence Rozsnyai, Vice President of Intellectual Property, Lycia Therapeutics | Reena Bajpai, Senior Counsel II, Gilead Sciences

WATCH: Strategies for success - patent drafting and application

Panellists from IGM Biosciences, Lycia Therapeutics, Gilead Sciences, and Morgan Lewis delve into how thoughtful patent drafting can improve prosecution outcomes and strengthen overall IP strategy.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Natera targets ex-employee over mass file download before rival move
19 February 2026   The genetic testing firm claims that a former oncology specialist stole hundreds of confidential files in the dead of night, days before moving to a competitor.
Americas
New rankings recognise top US patent firms and lawyers
13 February 2026   This year’s featured firms and individuals ranked by sister title WIPR, include those instructed on the biggest tech and life sciences cases, as well as the strategists devising global AI patent portfolios.
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026   Telehealth platform faces legal action from the Danish pharma giant, as well as FDA pressure over GLP-1 drugs and a drop in shares after discontinuing new product.


Editor's picks

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

Editor's picks

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025

More features

Natera targets ex-employee over mass file download before rival move
Hogan Lovells makes senior public and administrative hire in Italy
Danaher moves to acquire Masimo in $9.9bn deal
Generic rival blocked as AZ defends diabetes stronghold
Emotional Perception exclusive: ‘We are now very much open for business’
New rankings recognise top US patent firms and lawyers
Norton Rose Fulbright expands pharma and biotech disputes team
UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents